Risk-benefit analysis of restricting antimicrobial prescribing in children: what do we really know?
about
Antibiotics for sore throatAntibiotics for sore throatAntibiotic use for upper respiratory tract infections in children: a cross-sectional survey of knowledge, attitudes, and practices (KAP) of parents in Greece.Reducing antibiotic prescribing for children with respiratory tract infections in primary care: a systematic review.Clinical presentation and microbiological diagnosis in paediatric respiratory tract infection: a systematic reviewBacteria Etiological Agents Causing Lower Respiratory Tract Infections and Their Resistance Patterns.Diagnosis and treatment of acute otitis media: review.Trends in Antibiotic Use by Birth Season and Birth Year.Can pay-for-performance to primary care providers stimulate appropriate use of antibiotics?General antibiotic exposure is associated with increased risk of developing chronic rhinosinusitis.Antibiotic prescribing for children in primary care and adherence to treatment guidelines.Throat swabs in children with respiratory tract infection: associations with clinical presentation and potential targets for point-of-care testing.Did the accuracy of oral amoxicillin dosing of children improve after British National Formulary dose revisions in 2014? National cross-sectional survey in England.Antibiotic use and bacterial complications following upper respiratory tract infections: a population-based study.Decreased paediatric antibiotic consumption in France between 2000 and 2010.Impact of antibiotics for children presenting to general practice with cough on adverse outcomes: secondary analysis from a multicentre prospective cohort study
P2860
Q24202536-B2F935C7-82FE-42A1-A4E1-B2F3CA78842EQ24243911-1231959A-E283-4144-9B74-223959B1060BQ33950907-0938950A-0F08-4A74-B925-6B8D6CCBD7E7Q34802716-0CA2F258-AFEC-47D2-99A7-0A923103E729Q35075970-B9667F64-DB71-4A29-994C-DBA1DDE2E751Q36292069-BB06498C-9565-4937-8952-8E0EC5C48989Q38027253-421D03E2-440D-46CF-A52D-0FC146213C4AQ38625005-B6222761-3C19-4EF7-A67F-1DF5CD7C4020Q38689746-F8E0E57E-CE57-46A5-AED1-336F5A58AEB5Q38934316-EC50B75B-3308-4490-96B9-0AB6327AD3F8Q39945906-06585618-6642-4C07-8E14-A4706BB23AC4Q40277584-9E490DBC-AED3-444C-BE0B-22AEAA09AD9AQ41956994-8F8534BF-DAC5-4A26-8AE8-0C2560BBE8B0Q47156289-5DCD09FE-BB9C-4203-83C6-76191E1B7572Q47912520-962E63F5-78B9-448D-971F-F3BB05E41D8FQ57404662-40A40B9D-F215-44E6-B8B7-85A7A8225975
P2860
Risk-benefit analysis of restricting antimicrobial prescribing in children: what do we really know?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Risk-benefit analysis of restr ...... ldren: what do we really know?
@en
Risk-benefit analysis of restr ...... ldren: what do we really know?
@nl
type
label
Risk-benefit analysis of restr ...... ldren: what do we really know?
@en
Risk-benefit analysis of restr ...... ldren: what do we really know?
@nl
prefLabel
Risk-benefit analysis of restr ...... ldren: what do we really know?
@en
Risk-benefit analysis of restr ...... ldren: what do we really know?
@nl
P1476
Risk-benefit analysis of restr ...... ldren: what do we really know?
@en
P2093
Joanna Murray
Tamara Keith
P304
P356
10.1097/QCO.0B013E328338C46D
P577
2010-06-01T00:00:00Z